Literature DB >> 1465458

Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.

R D Finkelman1, N H Bell, D D Strong, L M Demers, D J Baylink.   

Abstract

Previous work showed that production of transforming growth factor beta (TGF-beta) by osteoblast-like rat UMR 106 cells was increased by 17 beta-estradiol at physiological concentrations. To determine whether ovariectomy alters the concentration of TGF-beta in rat long bones, female Sprague-Dawley rats were either sham-operated (n = 19) or ovariectomized (n = 19), pair-fed a semisynthetic diet for 6 weeks, and sacrificed. Tibial and femoral diaphyses were removed and extracted by demineralization. Ovariectomy lowered serum estrogen; did not alter body weight, serum magnesium, or serum 1,25-dihydroxyvitamin D; and produced only modest differences in serum calcium and phosphate concentrations. Hydroxyproline was higher and extractable protein was lower in bones from ovariectomized rats than in bones from sham-operated rats; calcium content did not differ between the two groups of animals. Ovariectomy lowered the concentration of TGF-beta in bone but did not change the concentration of insulin-like growth factors I or II compared with values in bone from control animals. The reduction of bone TGF-beta was evident 6 weeks after surgery but not at 3 weeks. Treatment of ovariectomized rats with estrogen eliminated the TGF-beta deficit. To determine whether 17 beta-estradiol increased TGF-beta production by normal bone cells, mouse osteoblasts were treated for 2 days with 17 beta-estradiol. The production of TGF-beta was increased almost 2-fold by 1 nM 17 beta-estradiol, and short-term treatment stimulated the intracellular accumulation of TGF-beta 1 mRNA. We conclude that ovariectomy reduces deposition of TGF-beta in rat bone and that diminished skeletal TGF-beta could play a role in the pathogenesis of bone loss, fractures, and microfractures that occur in estrogen-deficient states. Our results support the possibility that estrogen and bone TGF-beta may be necessary for normal maintenance of the skeleton in female rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465458      PMCID: PMC50724          DOI: 10.1073/pnas.89.24.12190

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  ESTIMATION OF HYDROXYPROLINE BY THE AUTOANALYSER.

Authors:  R A GRANT
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

2.  Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium.

Authors:  S Mohan; C M Bautista; S J Herring; T A Linkhart; D J Baylink
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

3.  Direct method for determining inorganic phosphate in serum with the "CentrifiChem".

Authors:  J A Daly; G Ertingshausen
Journal:  Clin Chem       Date:  1972-03       Impact factor: 8.327

4.  Evaluation of the pathogenesis of skeletal changes in ovariectomized rats.

Authors:  D N Kalu
Journal:  Endocrinology       Date:  1984-08       Impact factor: 4.736

5.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

6.  Determination of serum calcium by means of orthocresolphthalein complexone.

Authors:  H V Connerty; A R Briggs
Journal:  Am J Clin Pathol       Date:  1966-03       Impact factor: 2.493

7.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

8.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.

Authors:  T A Reinhardt; R L Horst; J W Orf; B W Hollis
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

9.  Skeletal alterations in ovariectomized rats.

Authors:  T J Wronski; P L Lowry; C C Walsh; L A Ignaszewski
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

10.  Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats.

Authors:  T J Wronski; C C Walsh; L A Ignaszewski
Journal:  Bone       Date:  1986       Impact factor: 4.398

View more
  19 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  RANK ligand and the regulation of skeletal remodeling.

Authors:  Norman H Bell
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency.

Authors:  Michaela Robbie Ryan; Rebecca Shepherd; Jennifer K Leavey; Yuhao Gao; Francesco Grassi; Frederick J Schnell; Wei-Ping Qian; Gilbert J Kersh; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-02       Impact factor: 11.205

Review 4.  Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors.

Authors:  J R Hawse; M Subramaniam; J N Ingle; M J Oursler; N M Rajamannan; T C Spelsberg
Journal:  J Cell Biochem       Date:  2008-02-01       Impact factor: 4.429

5.  Estrogen prevents bone loss through transforming growth factor beta signaling in T cells.

Authors:  Yuhao Gao; Wei-Ping Qian; Kimberly Dark; Gianluca Toraldo; Angela S P Lin; Robert E Guldberg; Richard A Flavell; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-05       Impact factor: 11.205

Review 6.  Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures.

Authors:  L M McNamara
Journal:  J R Soc Interface       Date:  2009-10-21       Impact factor: 4.118

7.  An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone.

Authors:  V Nicolas; S Mohan; Y Honda; A Prewett; R D Finkelman; D J Baylink; J R Farley
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

8.  Poor histological healing of a femoral fracture following 12 months of oestrogen deficiency in rats.

Authors:  R A Oliver; Y Yu; G Yee; A K Low; A D Diwan; W R Walsh
Journal:  Osteoporos Int       Date:  2013-04-06       Impact factor: 4.507

9.  Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.

Authors:  J Pfeilschifter; F Laukhuf; B Müller-Beckmann; W F Blum; T Pfister; R Ziegler
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  The effect of orchidectomy on thyroid C cells and bone histomorphometry in middle-aged rats.

Authors:  Branko Filipović; Branka Sosić-Jurjević; Vladimir Ajdzanović; Svetlana Trifunović; Milica Manojlović-Stojanoski; Natasa Ristić; Natasa Nestorović; Verica Milosević; Milka Sekulić
Journal:  Histochem Cell Biol       Date:  2007-07-03       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.